Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02846766
Title Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Teresa Helsten, MD
Indications

Advanced Solid Tumor

Therapies

Lenvatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST